CALCIUM CARBONATE

CALCIUM CARBONATE was reported 66236 times

CALCIUM CARBONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MILK-ALKALI SYNDROME 370 0.7075
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 102 0.5698
2 VAGINAL FLATULENCE 169 0.5578
3 LUPUS VULGARIS 621 0.4929
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 317 0.4746
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 943 0.4708
6 GRIP STRENGTH 107 0.4672
7 PULMONARY VASCULITIS 229 0.4257
8 C-REACTIVE PROTEIN 389 0.4196
9 SWOLLEN JOINT COUNT INCREASED 1294 0.4054
10 RHEUMATIC FEVER 1750 0.3922
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 801 0.3862
12 FACET JOINT SYNDROME 1223 0.3753
13 TOTAL LUNG CAPACITY INCREASED 102 0.3750
14 TOTAL LUNG CAPACITY ABNORMAL 139 0.3573
15 SWOLLEN JOINT COUNT 89 0.3560
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 190 0.3387
17 SLEEP DISORDER THERAPY 67 0.3384
18 DISLOCATION OF VERTEBRA 770 0.3373
19 NEUROLOGIC NEGLECT SYNDROME 183 0.3291
20 X-RAY ABNORMAL 551 0.3078
21 RETINITIS 478 0.2765
22 SPIROMETRY ABNORMAL 164 0.2742
23 CAPILLARITIS 73 0.2645
24 DUODENAL ULCER PERFORATION 1930 0.2593
25 RHEUMATOID FACTOR POSITIVE 1458 0.2522
26 MITE ALLERGY 161 0.2458
27 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 246 0.2316
28 CAROTID ARTERY THROMBOSIS 185 0.2179
29 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 158 0.2156
30 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1509 0.2104
31 PERIPHERAL VENOUS DISEASE 850 0.2079
32 SERONEGATIVE ARTHRITIS 233 0.2033
33 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 104 0.1989
34 ANALGESIC THERAPY 63 0.1963
35 MYCOTIC ALLERGY 166 0.1942
36 HYPOCHOLESTEROLAEMIA 68 0.1926
37 HYPERPARATHYROIDISM SECONDARY 482 0.1922
38 HELICOBACTER INFECTION 1972 0.1917
39 APPENDICOLITH 71 0.1835
40 NEPHROGENIC ANAEMIA 832 0.1794
41 PEMPHIGUS 2186 0.1747
42 C-REACTIVE PROTEIN ABNORMAL 1116 0.1738
43 MUSCLE INJURY 1407 0.1696
44 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1089 0.1675
45 DUST ALLERGY 164 0.1672
46 HAND DEFORMITY 2115 0.1611
47 FOLLICULITIS 1638 0.1560
48 NEURITIS 236 0.1528
49 BONE EROSION 520 0.1469
50 REBOUND ACID HYPERSECRETION 439 0.1450
51 ADJUSTMENT DISORDER 184 0.1415
52 MULTIPLE DRUG THERAPY 103 0.1366
53 PORPHYRIA ACUTE 191 0.1331
54 LIP DRY 1186 0.1304
55 BREAST CANCER STAGE III 797 0.1229
56 PERICARDITIS 2015 0.1198
57 JOINT RANGE OF MOTION DECREASED 1571 0.1170
58 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 236 0.1156
59 CALCIUM DEFICIENCY 149 0.1150
60 SYNOVITIS 2064 0.1144
61 CONJUNCTIVITIS ALLERGIC 168 0.1134
62 HYPERCHOLESTEROLAEMIA 1079 0.1116
63 GRIP STRENGTH DECREASED 978 0.1110
64 FEMALE GENITAL TRACT FISTULA 184 0.1077
65 WOUND INFECTION 1135 0.1035
66 RESPIRATORY SYMPTOM 287 0.1008
67 GLOSSODYNIA 2258 0.1008
68 RECALLED PRODUCT 169 0.0976
69 AUTOIMMUNE DISORDER 921 0.0944
70 END STAGE RENAL DISEASE 1709 0.0936
71 NASAL OEDEMA 167 0.0924
72 BURSITIS 1111 0.0915
73 ONYCHOMADESIS 363 0.0864
74 DRUG TOLERANCE DECREASED 241 0.0857
75 IRRITABLE BOWEL SYNDROME 1761 0.0820
76 FIBROMYALGIA 1994 0.0819
77 LIVER INJURY 2002 0.0815
78 STEROID DEPENDENCE 71 0.0809
79 OBSTRUCTIVE SLEEP APNOEA SYNDROME 117 0.0802
80 LIVE BIRTH 666 0.0795
81 WOUND 2216 0.0792
82 RADICULOPATHY 205 0.0777
83 HYPERPHOSPHATAEMIA 164 0.0762
84 CHRONIC SINUSITIS 286 0.0761
85 BLEPHAROSPASM 466 0.0739
86 EXOSTOSIS 659 0.0721
87 PERSONALITY DISORDER 187 0.0713
88 SCIATICA 1133 0.0710
89 ONYCHOMYCOSIS 307 0.0699
90 SYSTEMIC LUPUS ERYTHEMATOSUS 2473 0.0696
91 MYOGLOBIN BLOOD INCREASED 105 0.0686
92 CATARRH 61 0.0675
93 PULMONARY FIBROSIS 1284 0.0669
94 CHRONIC KIDNEY DISEASE 4969 0.0653
95 PROCTITIS 183 0.0653
96 NEPHROCALCINOSIS 77 0.0649
97 NORMOCHROMIC NORMOCYTIC ANAEMIA 189 0.0629
98 TYPE 2 DIABETES MELLITUS 2058 0.0611
99 METABOLIC ALKALOSIS 98 0.0611
100 DEATH NEONATAL 84 0.0603
101 WALKING AID USER 397 0.0602
102 OBESITY 931 0.0584
103 PSORIATIC ARTHROPATHY 2360 0.0581
104 MATERNAL EXPOSURE TIMING UNSPECIFIED 216 0.0574
105 LOWER LIMB FRACTURE 1091 0.0567
106 PUSTULAR PSORIASIS 195 0.0567
107 NASAL OBSTRUCTION 104 0.0554
108 FORCED EXPIRATORY VOLUME DECREASED 157 0.0554
109 OBSTRUCTIVE AIRWAYS DISORDER 615 0.0552
110 IMPAIRED HEALING 1814 0.0552
111 CALCIPHYLAXIS 101 0.0550
112 LUPUS-LIKE SYNDROME 497 0.0547
113 JAUNDICE CHOLESTATIC 190 0.0537
114 SEDATION COMPLICATION 135 0.0529
115 CONTRAINDICATED PRODUCT ADMINISTERED 1597 0.0527
116 HYPOMANIA 193 0.0524
117 BREAST CANCER STAGE II 436 0.0524
118 FULL BLOOD COUNT ABNORMAL 550 0.0520
119 NAIL DISORDER 447 0.0510
120 PRESCRIBED OVERDOSE 981 0.0506
121 JOINT DISLOCATION 522 0.0493
122 RED BLOOD CELL SEDIMENTATION RATE INCREASED 539 0.0487
123 ULCER HAEMORRHAGE 325 0.0480
124 WHEEZING 2821 0.0475
125 FINGER DEFORMITY 230 0.0474
126 SPONDYLITIS 167 0.0459
127 FOOT DEFORMITY 503 0.0453
128 HYPERCALCAEMIA 557 0.0451
129 ARTERIOSCLEROSIS CORONARY ARTERY 298 0.0449
130 HIP ARTHROPLASTY 668 0.0436
131 PULMONARY ALVEOLAR HAEMORRHAGE 244 0.0435
132 NEUROLOGICAL SYMPTOM 247 0.0432
133 MACULAR DEGENERATION 510 0.0427
134 BRAIN NATRIURETIC PEPTIDE INCREASED 131 0.0424
135 BLOOD PHOSPHORUS INCREASED 116 0.0424
136 RASH VESICULAR 205 0.0424
137 GAIT INABILITY 1411 0.0422
138 BLOOD CHOLESTEROL INCREASED 1959 0.0420
139 ARTHROPATHY 2289 0.0411
140 OSTEOARTHRITIS 1700 0.0401
141 NASAL POLYPS 192 0.0390
142 PLANTAR FASCIITIS 129 0.0384
143 PRESCRIBED UNDERDOSE 765 0.0383
144 PRODUCT LABEL CONFUSION 222 0.0381
145 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 646 0.0380
146 HYPOCALCAEMIA 712 0.0376
147 CREATININE RENAL CLEARANCE DECREASED 150 0.0374
148 BLOOD CALCIUM DECREASED 415 0.0369
149 HYPERPARATHYROIDISM 76 0.0368
150 BRONCHIECTASIS 247 0.0366
151 EYE INJURY 111 0.0365
152 RENAL INJURY 1067 0.0359
153 LOWER RESPIRATORY TRACT INFECTION 1627 0.0357
154 INFUSION RELATED REACTION 2351 0.0354
155 BURNS SECOND DEGREE 61 0.0347
156 OSTEOPOROSIS 1421 0.0345
157 COELIAC DISEASE 328 0.0334
158 HEPATIC ENZYME INCREASED 2272 0.0333
159 GASTROOESOPHAGEAL REFLUX DISEASE 2647 0.0328
160 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 561 0.0327
161 GANGRENE 197 0.0327
162 STOMATITIS 1979 0.0326
163 TUBULOINTERSTITIAL NEPHRITIS 609 0.0325
164 C-REACTIVE PROTEIN INCREASED 1181 0.0324
165 OEDEMA 1751 0.0323
166 MOBILITY DECREASED 2296 0.0319
167 BLISTER 1792 0.0319
168 TETANY 58 0.0318
169 BACK INJURY 343 0.0315
170 NIGHT SWEATS 1011 0.0313
171 ESSENTIAL HYPERTENSION 57 0.0311
172 HEPATIC CIRRHOSIS 580 0.0308
173 RHINITIS ALLERGIC 136 0.0305
174 MYOSITIS 270 0.0301
175 BLOOD CALCIUM INCREASED 263 0.0300
176 CARDIAC MURMUR 259 0.0299
177 ROAD TRAFFIC ACCIDENT 1237 0.0295
178 KNEE ARTHROPLASTY 617 0.0293
179 LABYRINTHITIS 74 0.0292
180 VITAMIN D DEFICIENCY 285 0.0292
181 ARTERIOSCLEROSIS 273 0.0290
182 DELIRIUM 1002 0.0288
183 BLOOD PARATHYROID HORMONE INCREASED 84 0.0288
184 SPINAL FUSION SURGERY 117 0.0288
185 DISCOMFORT 1733 0.0284
186 LUNG DISORDER 1389 0.0283
187 INJURY 1986 0.0282
188 HYPOPHOSPHATAEMIA 207 0.0280
189 GENERAL SYMPTOM 209 0.0279
190 THROAT CLEARING 103 0.0275
191 TASTE DISORDER 556 0.0274
192 THERAPEUTIC PRODUCT EFFECT DECREASED 1214 0.0271
193 OSTEITIS 68 0.0269
194 SENSORY LOSS 217 0.0269
195 SARCOIDOSIS 128 0.0269
196 INFUSION SITE REACTION 79 0.0264
197 SWELLING 2467 0.0263
198 DYSPEPSIA 2580 0.0262
199 NEPHROGENIC SYSTEMIC FIBROSIS 79 0.0261
200 RENAL TUBULAR NECROSIS 256 0.0261
201 INFLAMMATION 1346 0.0261
202 ARTERIAL OCCLUSIVE DISEASE 203 0.0258
203 VASCULITIS 300 0.0257
204 MUSCLE SPASTICITY 314 0.0255
205 RHEUMATOID ARTHRITIS 2897 0.0255
206 NEPHROPATHY 237 0.0254
207 LOOSE TOOTH 81 0.0251
208 SLEEP DISORDER 1750 0.0248
209 BLOOD PRESSURE DIASTOLIC ABNORMAL 63 0.0247
210 ACUTE KIDNEY INJURY 3768 0.0246
211 LIVER DISORDER 1080 0.0243
212 MUSCULOSKELETAL PAIN 1274 0.0243
213 RENAL FAILURE 3176 0.0239
214 CONGENITAL ANOMALY 184 0.0237
215 MUSCULOSKELETAL STIFFNESS 2078 0.0237
216 FIBULA FRACTURE 68 0.0236
217 HEMIPLEGIA 196 0.0235
218 JOINT STIFFNESS 615 0.0234
219 LIVER FUNCTION TEST INCREASED 498 0.0232
220 IRON DEFICIENCY 104 0.0231
221 NORMAL NEWBORN 125 0.0230
222 BACK DISORDER 369 0.0227
223 AORTIC STENOSIS 79 0.0227
224 SCHIZOPHRENIA 274 0.0225
225 OSTEOPENIA 342 0.0225
226 SPUTUM DISCOLOURED 213 0.0224
227 ALCOHOL POISONING 60 0.0224
228 BONE DISORDER 405 0.0222
229 SINUS CONGESTION 299 0.0221
230 ILL-DEFINED DISORDER 1335 0.0220
231 BREATH SOUNDS ABNORMAL 108 0.0219
232 MOTOR DYSFUNCTION 222 0.0218
233 DRUG INTOLERANCE 2099 0.0217
234 GENERAL PHYSICAL HEALTH DETERIORATION 2491 0.0215
235 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 109 0.0215
236 FIBROSIS 65 0.0211
237 FREQUENT BOWEL MOVEMENTS 570 0.0211
238 JOINT SWELLING 2535 0.0210
239 EPILEPSY 641 0.0209
240 MULTIPLE FRACTURES 344 0.0209
241 SINUSITIS 2145 0.0209
242 RENAL FUNCTION TEST ABNORMAL 97 0.0209
243 CHEST X-RAY ABNORMAL 64 0.0209
244 ORAL CANDIDIASIS 274 0.0208
245 TIBIA FRACTURE 97 0.0207
246 STRESS FRACTURE 111 0.0206
247 RESPIRATORY TRACT INFECTION 533 0.0204
248 COORDINATION ABNORMAL 285 0.0204
249 EAR PAIN 397 0.0204
250 DRY MOUTH 1656 0.0204
251 DYSLIPIDAEMIA 103 0.0203
252 DRUG-INDUCED LIVER INJURY 633 0.0202
253 AFFECT LABILITY 194 0.0201
254 ASTHMA 2278 0.0201
255 WRIST FRACTURE 239 0.0199
256 EAR INFECTION 530 0.0199
257 INTENTIONAL PRODUCT USE ISSUE 1733 0.0198
258 NODULE 258 0.0197
259 MATERNAL EXPOSURE DURING PREGNANCY 1756 0.0197
260 HYPOPNOEA 68 0.0196
261 DISABILITY 383 0.0193
262 RHINITIS 156 0.0193
263 RALES 112 0.0193
264 UPPER-AIRWAY COUGH SYNDROME 158 0.0192
265 EXERCISE TOLERANCE DECREASED 110 0.0191
266 ABDOMINAL DISCOMFORT 3173 0.0189
267 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1345 0.0189
268 SPINAL OSTEOARTHRITIS 165 0.0188
269 GASTROINTESTINAL DISORDER 1678 0.0187
270 CONTUSION 1796 0.0186
271 SECRETION DISCHARGE 233 0.0186
272 EXPOSURE DURING PREGNANCY 1155 0.0186
273 VASCULAR DEVICE INFECTION 84 0.0185
274 INTERVERTEBRAL DISC DEGENERATION 170 0.0184
275 ARTHRITIS 1445 0.0184
276 APLASIA PURE RED CELL 63 0.0183
277 SINUS DISORDER 359 0.0181
278 BLOOD URIC ACID INCREASED 104 0.0180
279 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 858 0.0178
280 HYPERLIPIDAEMIA 213 0.0178
281 VAGINAL DISCHARGE 180 0.0178
282 CUSHINGOID 57 0.0177
283 CLOSTRIDIUM DIFFICILE COLITIS 188 0.0177
284 ANGIOPATHY 99 0.0176
285 RESPIRATORY TRACT CONGESTION 279 0.0175
286 LEFT VENTRICULAR HYPERTROPHY 75 0.0175
287 DRUG TOLERANCE 88 0.0174
288 THERAPY NON-RESPONDER 775 0.0172
289 AMNESIA 1117 0.0172
290 HYPOMAGNESAEMIA 239 0.0171
291 HYPOAESTHESIA 2564 0.0171
292 PATHOLOGICAL FRACTURE 86 0.0169
293 PARAESTHESIA ORAL 243 0.0168
294 ATELECTASIS 162 0.0167
295 HYPOVOLAEMIA 98 0.0167
296 CONFUSIONAL STATE 2697 0.0167
297 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 68 0.0166
298 ADVERSE REACTION 220 0.0166
299 INCREASED UPPER AIRWAY SECRETION 85 0.0165
300 SPINAL COMPRESSION FRACTURE 134 0.0162
301 LUNG NEOPLASM 69 0.0161
302 WEIGHT FLUCTUATION 169 0.0161
303 BLOOD PRESSURE INADEQUATELY CONTROLLED 97 0.0161
304 LOW TURNOVER OSTEOPATHY 64 0.0160
305 BLOOD ALBUMIN DECREASED 127 0.0160
306 PNEUMONIA ASPIRATION 397 0.0159
307 BLOOD PHOSPHORUS DECREASED 58 0.0159
308 RENAL CYST 126 0.0158
309 COMPRESSION FRACTURE 85 0.0158
310 TREATMENT FAILURE 1314 0.0158
311 HEMIPARESIS 268 0.0158
312 CHOLELITHIASIS 515 0.0157
313 PROTEIN TOTAL DECREASED 59 0.0157
314 OEDEMA PERIPHERAL 1910 0.0157
315 SKIN HAEMORRHAGE 232 0.0156
316 HUMERUS FRACTURE 75 0.0155
317 HYPERTENSION 3286 0.0155
318 RENAL FAILURE CHRONIC 119 0.0155
319 RECTAL HAEMORRHAGE 664 0.0154
320 SENSATION OF FOREIGN BODY 130 0.0154
321 RED CELL DISTRIBUTION WIDTH INCREASED 64 0.0154
322 DIVERTICULUM 109 0.0153
323 FOOT FRACTURE 290 0.0153
324 EATING DISORDER 322 0.0151
325 GINGIVAL PAIN 120 0.0151
326 BODY HEIGHT DECREASED 160 0.0149
327 MIGRAINE 1426 0.0149
328 UPPER RESPIRATORY TRACT INFECTION 690 0.0149
329 PREGNANCY 299 0.0149
330 BLOOD MAGNESIUM DECREASED 128 0.0148
331 HAEMOPTYSIS 413 0.0148
332 TROPONIN INCREASED 110 0.0144
333 HYPERTRANSAMINASAEMIA 100 0.0144
334 COLITIS ULCERATIVE 642 0.0143
335 BENIGN PROSTATIC HYPERPLASIA 74 0.0143
336 ORTHOSTATIC HYPOTENSION 248 0.0142
337 NASOPHARYNGITIS 2619 0.0142
338 LUMBAR VERTEBRAL FRACTURE 65 0.0142
339 SUSPECTED OFF LABEL USE 64 0.0142
340 PRODUCTIVE COUGH 676 0.0141
341 MUSCULAR WEAKNESS 1607 0.0141
342 MYASTHENIA GRAVIS 114 0.0141
343 PERIPHERAL SWELLING 2152 0.0140
344 BLOOD PRESSURE DIASTOLIC INCREASED 64 0.0139
345 RESPIRATORY DISORDER 413 0.0138
346 STAPHYLOCOCCAL SEPSIS 68 0.0138
347 ALOPECIA 2700 0.0137
348 TOOTH FRACTURE 151 0.0137
349 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 712 0.0136
350 SNEEZING 305 0.0136
351 APPETITE DISORDER 90 0.0136
352 STAPHYLOCOCCAL BACTERAEMIA 59 0.0136
353 KIDNEY TRANSPLANT REJECTION 65 0.0135
354 RIB FRACTURE 277 0.0135
355 INFECTION 1936 0.0134
356 TRICUSPID VALVE INCOMPETENCE 106 0.0133
357 EOSINOPHIL COUNT INCREASED 111 0.0133
358 HIATUS HERNIA 172 0.0133
359 HYPOTHYROIDISM 424 0.0133
360 SCOLIOSIS 82 0.0132
361 DYSPNOEA EXERTIONAL 496 0.0132
362 HYPERSENSITIVITY 2441 0.0131
363 ANKLE FRACTURE 203 0.0131
364 PROCTALGIA 84 0.0131
365 TENDERNESS 136 0.0130
366 SYNOVIAL CYST 60 0.0130
367 HAND FRACTURE 92 0.0130
368 IRON DEFICIENCY ANAEMIA 119 0.0129
369 URTICARIA 2151 0.0128
370 ELECTROLYTE IMBALANCE 149 0.0128
371 SEASONAL ALLERGY 181 0.0128
372 PNEUMONIA 4122 0.0127
373 CHEST PAIN 2357 0.0127
374 ULCER 202 0.0127
375 PROTEIN URINE PRESENT 63 0.0126
376 APPENDICITIS 118 0.0126
377 TOXIC EPIDERMAL NECROLYSIS 191 0.0126
378 BLOOD PRESSURE SYSTOLIC INCREASED 245 0.0125
379 HYPOXIA 441 0.0125
380 SPINAL COLUMN STENOSIS 59 0.0125
381 PNEUMOTHORAX 197 0.0124
382 CYSTITIS 393 0.0123
383 GOUT 221 0.0123
384 ARTHRITIS INFECTIVE 57 0.0123
385 VITAMIN D DECREASED 105 0.0123
386 FLANK PAIN 115 0.0123
387 WEIGHT INCREASED 2737 0.0122
388 BLOOD TEST ABNORMAL 171 0.0122
389 HYDRONEPHROSIS 91 0.0121
390 FAILURE TO THRIVE 63 0.0121
391 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 66 0.0121
392 BLOOD UREA INCREASED 203 0.0121
393 SQUAMOUS CELL CARCINOMA OF SKIN 73 0.0121
394 ABDOMINAL TENDERNESS 60 0.0121
395 SPINAL FRACTURE 242 0.0121
396 FEMUR FRACTURE 374 0.0121
397 HAEMATOCRIT DECREASED 239 0.0120
398 ACUTE RESPIRATORY FAILURE 230 0.0119
399 ANAL FISSURE 64 0.0119
400 DECREASED APPETITE 2767 0.0119
401 HEPATOTOXICITY 265 0.0119
402 VENTRICULAR FIBRILLATION 132 0.0119
403 OESOPHAGITIS 129 0.0118
404 PAROSMIA 89 0.0118
405 BLOOD PRESSURE DIASTOLIC DECREASED 87 0.0118
406 NECK PAIN 653 0.0117
407 ABDOMINAL PAIN UPPER 2388 0.0116
408 HYPERVOLAEMIA 57 0.0115
409 PRE-EXISTING CONDITION IMPROVED 72 0.0115
410 COLITIS 432 0.0114
411 POLYARTHRITIS 60 0.0114
412 HAEMORRHOIDS 222 0.0114
413 BLOOD BILIRUBIN INCREASED 307 0.0114
414 OVERWEIGHT 61 0.0113
415 FEMORAL NECK FRACTURE 58 0.0113
416 MEMORY IMPAIRMENT 1552 0.0113
417 ASPHYXIA 92 0.0113
418 CONDITION AGGRAVATED 3414 0.0112
419 PELVIC FRACTURE 87 0.0112
420 ANGINA PECTORIS 320 0.0112
421 EMPHYSEMA 112 0.0111
422 MULTIPLE ALLERGIES 87 0.0111
423 HEPATITIS 280 0.0109
424 ASPIRATION 118 0.0108
425 CORONARY ARTERY DISEASE 326 0.0108
426 PYREXIA 3694 0.0107
427 BODY TEMPERATURE DECREASED 105 0.0107
428 CARPAL TUNNEL SYNDROME 149 0.0106
429 MICTURITION URGENCY 121 0.0106
430 BREAST MASS 71 0.0106
431 UROSEPSIS 97 0.0105
432 RHINORRHOEA 677 0.0105
433 CATARACT 623 0.0105
434 ABDOMINAL DISTENSION 1092 0.0105
435 MUSCLE SPASMS 1916 0.0104
436 HYPOKALAEMIA 481 0.0104
437 INTERVERTEBRAL DISC PROTRUSION 227 0.0104
438 VOMITING 4868 0.0103
439 LIGAMENT SPRAIN 102 0.0103
440 BLOOD CREATININE INCREASED 672 0.0103
441 RED BLOOD CELL COUNT DECREASED 294 0.0103
442 MEDICATION ERROR 571 0.0103
443 EOSINOPHILIA 179 0.0102
444 UPPER LIMB FRACTURE 203 0.0102
445 PERITONITIS BACTERIAL 102 0.0101
446 PAIN IN EXTREMITY 2969 0.0101
447 MITRAL VALVE INCOMPETENCE 114 0.0101
448 POOR VENOUS ACCESS 104 0.0100
449 PARAESTHESIA 1579 0.0100
450 GLOMERULAR FILTRATION RATE DECREASED 123 0.0100
451 ABDOMINAL PAIN 2319 0.0100
452 PRODUCT USE ISSUE 1872 0.0100
453 GAIT DISTURBANCE 1904 0.0099
454 DEPRESSION 2261 0.0099
455 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 288 0.0098
456 WHITE BLOOD CELL COUNT INCREASED 375 0.0098
457 BLOOD COUNT ABNORMAL 148 0.0098
458 CARDIOGENIC SHOCK 140 0.0097
459 UPPER GASTROINTESTINAL HAEMORRHAGE 164 0.0097
460 TRANSFUSION 102 0.0097
461 ADVERSE DRUG REACTION 874 0.0097
462 GASTROENTERITIS 142 0.0097
463 ESCHERICHIA INFECTION 80 0.0097
464 LABORATORY TEST ABNORMAL 285 0.0096
465 ATRIAL FLUTTER 77 0.0096
466 NEPHROLITHIASIS 441 0.0096
467 FEBRILE NEUTROPENIA 637 0.0096
468 HIP FRACTURE 308 0.0096
469 WEIGHT DECREASED 2667 0.0095
470 ARTHRALGIA 3970 0.0095
471 BLOOD POTASSIUM DECREASED 287 0.0095
472 BACTERIAL INFECTION 178 0.0095
473 ORAL PAIN 213 0.0095
474 LUNG INFILTRATION 84 0.0095
475 FLUID OVERLOAD 138 0.0095
476 PYELONEPHRITIS 82 0.0095
477 BRONCHITIS 700 0.0094
478 APHASIA 285 0.0094
479 SMALL INTESTINAL OBSTRUCTION 116 0.0094
480 CHOLECYSTITIS CHRONIC 63 0.0094
481 HYPOALBUMINAEMIA 73 0.0094
482 FLUID RETENTION 477 0.0094
483 CARDIOMEGALY 115 0.0093
484 HEPATIC STEATOSIS 174 0.0093
485 HYPERKALAEMIA 327 0.0093
486 CHOLECYSTITIS 111 0.0093
487 HYPONATRAEMIA 524 0.0093
488 ASTHENIA 3480 0.0092
489 BONE DENSITY DECREASED 289 0.0092
490 BLOOD ALKALINE PHOSPHATASE INCREASED 227 0.0091
491 TRANSPLANT REJECTION 73 0.0091
492 DYSARTHRIA 343 0.0091
493 BONE PAIN 533 0.0091
494 ERUCTATION 176 0.0091
495 PRODUCT USE IN UNAPPROVED INDICATION 2251 0.0091
496 NEUTROPHIL COUNT INCREASED 93 0.0091
497 URINE OUTPUT DECREASED 79 0.0090
498 ADVERSE EVENT 831 0.0090
499 PLEURAL EFFUSION 548 0.0090
500 CONSTIPATION 1956 0.0090
501 MENTAL STATUS CHANGES 249 0.0090
502 DYSPNOEA 5066 0.0089
503 HAEMATOCHEZIA 493 0.0089
504 MALAISE 3909 0.0089
505 ACIDOSIS 68 0.0089
506 ANAL INCONTINENCE 80 0.0089
507 HAEMOGLOBIN DECREASED 909 0.0088
508 MALNUTRITION 99 0.0088
509 FALL 2934 0.0088
510 MYOCARDIAL ISCHAEMIA 100 0.0088
511 BOWEL MOVEMENT IRREGULARITY 67 0.0087
512 PSYCHOTIC DISORDER 258 0.0087
513 ATRIAL FIBRILLATION 849 0.0087
514 BLOOD PRESSURE FLUCTUATION 209 0.0087
515 JOINT EFFUSION 60 0.0087
516 BACTERAEMIA 103 0.0087
517 ASCITES 255 0.0087
518 PULMONARY EMBOLISM 824 0.0087
519 DEVICE RELATED INFECTION 133 0.0086
520 ANXIETY 2454 0.0086
521 PAIN 5274 0.0086
522 OSTEOMYELITIS 155 0.0086
523 FATIGUE 6657 0.0085
524 JOINT INJURY 182 0.0085
525 LIMB INJURY 231 0.0085
526 BLOOD SODIUM DECREASED 160 0.0085
527 DECUBITUS ULCER 69 0.0085
528 ANAEMIA 1613 0.0084
529 HAEMODIALYSIS 71 0.0084
530 RESPIRATORY RATE INCREASED 75 0.0084
531 GASTRIC ULCER 160 0.0084
532 LEUKOCYTOSIS 152 0.0084
533 SLEEP APNOEA SYNDROME 160 0.0084
534 RENAL IMPAIRMENT 701 0.0083
535 SPINAL DISORDER 79 0.0083
536 CROHN'S DISEASE 57 0.0083
537 CELLULITIS 419 0.0083
538 GROIN PAIN 73 0.0083
539 PROCEDURAL PAIN 230 0.0083
540 METASTASES TO BONE 136 0.0083
541 DIARRHOEA 5338 0.0083
542 PURPURA 73 0.0082
543 DIABETES MELLITUS INADEQUATE CONTROL 146 0.0082
544 DUODENAL ULCER 58 0.0082
545 MUSCULOSKELETAL DISCOMFORT 141 0.0082
546 COGNITIVE DISORDER 381 0.0082
547 RASH 3556 0.0081
548 PETECHIAE 85 0.0081
549 GALLBLADDER DISORDER 144 0.0081
550 CHEST DISCOMFORT 821 0.0080
551 LYMPHOCYTE COUNT DECREASED 141 0.0080
552 GASTRITIS 209 0.0079
553 NEURALGIA 193 0.0079
554 ELECTROCARDIOGRAM ABNORMAL 62 0.0079
555 INSOMNIA 2096 0.0079
556 BLADDER DISORDER 78 0.0078
557 ARTHROPOD BITE 58 0.0078
558 BLOOD POTASSIUM INCREASED 127 0.0078
559 ECONOMIC PROBLEM 118 0.0078
560 TOOTH DISORDER 173 0.0078
561 HAEMATURIA 265 0.0077
562 NASAL CONGESTION 454 0.0077
563 THROMBOSIS 621 0.0077
564 NAUSEA 6098 0.0077
565 DYSPHONIA 450 0.0077
566 BALANCE DISORDER 665 0.0077
567 BASAL CELL CARCINOMA 120 0.0077
568 PEMPHIGOID 58 0.0077
569 INFUSION SITE PAIN 99 0.0077
570 HYPOPHAGIA 196 0.0077
571 SEPSIS 853 0.0076
572 OROPHARYNGEAL DISCOMFORT 69 0.0076
573 IMPAIRED GASTRIC EMPTYING 104 0.0076
574 COUGH 2137 0.0076
575 ILEUS 94 0.0076
576 TOOTH ABSCESS 77 0.0076
577 MUSCULOSKELETAL CHEST PAIN 117 0.0076
578 FULL BLOOD COUNT DECREASED 152 0.0075
579 RESTLESS LEGS SYNDROME 137 0.0075
580 DYSPHAGIA 715 0.0075
581 TACHYCARDIA 669 0.0075
582 PAIN IN JAW 213 0.0075
583 BLOOD PRESSURE INCREASED 1147 0.0075
584 ADRENAL INSUFFICIENCY 91 0.0075
585 NOCTURIA 91 0.0075
586 PULMONARY HYPERTENSION 156 0.0075
587 SEPTIC SHOCK 325 0.0075
588 PERITONITIS 154 0.0074
589 PANCREATITIS 393 0.0074
590 CYTOKINE RELEASE SYNDROME 149 0.0074
591 LOW BIRTH WEIGHT BABY 59 0.0074
592 HEART RATE DECREASED 260 0.0074
593 URINARY TRACT INFECTION 1263 0.0074
594 MOUTH ULCERATION 156 0.0074
595 TOOTHACHE 134 0.0074
596 CARDIAC FAILURE CONGESTIVE 593 0.0074
597 COMA 351 0.0074
598 BLOOD IRON DECREASED 87 0.0073
599 TRANSAMINASES INCREASED 163 0.0073
600 THERAPEUTIC RESPONSE DECREASED 444 0.0073
601 DENTAL CARIES 81 0.0073
602 LEUKOPENIA 365 0.0073
603 FEELING HOT 445 0.0073
604 RENAL FAILURE ACUTE 308 0.0073
605 PULMONARY MASS 108 0.0072
606 DEHYDRATION 962 0.0072
607 HEADACHE 4521 0.0072
608 TOOTH INFECTION 95 0.0072
609 VISUAL IMPAIRMENT 893 0.0072
610 FLATULENCE 408 0.0072
611 CLOSTRIDIUM DIFFICILE INFECTION 157 0.0072
612 SKIN LACERATION 78 0.0072
613 IMMUNODEFICIENCY 106 0.0071
614 DIZZINESS 3534 0.0071
615 INTERNATIONAL NORMALISED RATIO INCREASED 202 0.0071
616 SKIN ULCER 182 0.0070
617 RENAL DISORDER 328 0.0070
618 DEEP VEIN THROMBOSIS 457 0.0070
619 PULMONARY OEDEMA 314 0.0070
620 MULTIPLE ORGAN DYSFUNCTION SYNDROME 198 0.0070
621 HAEMATOMA 181 0.0070
622 PNEUMONITIS 190 0.0070
623 ACUTE MYOCARDIAL INFARCTION 204 0.0069
624 BACK PAIN 1607 0.0069
625 PRESYNCOPE 168 0.0069
626 PALPITATIONS 806 0.0069
627 PSEUDOMONAS INFECTION 59 0.0069
628 PERICARDIAL EFFUSION 159 0.0069
629 BODY TEMPERATURE INCREASED 140 0.0069
630 SKIN LESION 188 0.0068
631 ROTATOR CUFF SYNDROME 88 0.0068
632 WHITE BLOOD CELL COUNT DECREASED 741 0.0068
633 SINUS TACHYCARDIA 97 0.0068
634 DIABETES MELLITUS 520 0.0068
635 BIPOLAR DISORDER 74 0.0068
636 COVID-19 PNEUMONIA 80 0.0068
637 RASH PRURITIC 367 0.0068
638 MELAENA 149 0.0068
639 INCREASED TENDENCY TO BRUISE 62 0.0067
640 HOT FLUSH 507 0.0067
641 INFLUENZA 749 0.0067
642 STAPHYLOCOCCAL INFECTION 221 0.0067
643 THROMBOCYTOPENIA 747 0.0067
644 FISTULA 75 0.0067
645 DIALYSIS 94 0.0066
646 UNDERDOSE 483 0.0066
647 SEDATION 173 0.0066
648 DRUG LEVEL DECREASED 67 0.0066
649 LYMPHOPENIA 93 0.0066
650 HEART RATE IRREGULAR 148 0.0065
651 GENERALISED OEDEMA 81 0.0065
652 IMPAIRED QUALITY OF LIFE 94 0.0065
653 PRURITUS 2512 0.0065
654 BRONCHOSPASM 93 0.0065
655 SUBDURAL HAEMATOMA 93 0.0065
656 HOSPICE CARE 64 0.0065
657 RETCHING 138 0.0065
658 PANCYTOPENIA 361 0.0065
659 BLOOD URINE PRESENT 122 0.0064
660 DEPRESSED LEVEL OF CONSCIOUSNESS 253 0.0064
661 ENCEPHALOPATHY 157 0.0064
662 METABOLIC ACIDOSIS 204 0.0064
663 LOCALISED INFECTION 154 0.0064
664 PLATELET COUNT INCREASED 83 0.0064
665 PSORIASIS 831 0.0064
666 SKIN DISORDER 212 0.0063
667 INCONTINENCE 67 0.0063
668 MUSCLE TWITCHING 146 0.0063
669 POLLAKIURIA 264 0.0063
670 PNEUMONIA BACTERIAL 58 0.0063
671 VIRAL INFECTION 210 0.0063
672 LUNG INFECTION 98 0.0063
673 MULTI-ORGAN FAILURE 109 0.0063
674 BLOOD THYROID STIMULATING HORMONE INCREASED 58 0.0063
675 MUSCLE TIGHTNESS 102 0.0063
676 PULMONARY CONGESTION 83 0.0063
677 RESPIRATORY DISTRESS 173 0.0063
678 SUPRAVENTRICULAR TACHYCARDIA 60 0.0063
679 GASTRIC DISORDER 215 0.0063
680 OXYGEN SATURATION DECREASED 352 0.0063
681 TENDON RUPTURE 77 0.0062
682 ATAXIA 74 0.0062
683 DYSSTASIA 182 0.0062
684 CARDIOMYOPATHY 92 0.0062
685 KIDNEY INFECTION 122 0.0062
686 RESPIRATORY FAILURE 451 0.0062
687 HYPOTENSION 1239 0.0062
688 OFF LABEL USE 5395 0.0062
689 MUSCLE ATROPHY 78 0.0062
690 NEUROPATHY PERIPHERAL 584 0.0061
691 ASPARTATE AMINOTRANSFERASE INCREASED 326 0.0061
692 GLAUCOMA 118 0.0061
693 TREATMENT NONCOMPLIANCE 335 0.0061
694 BLOOD LACTATE DEHYDROGENASE INCREASED 97 0.0061
695 OSTEONECROSIS OF JAW 151 0.0061
696 PLASMA CELL MYELOMA 238 0.0061
697 GASTROENTERITIS VIRAL 110 0.0061
698 INJECTION SITE REACTION 418 0.0061
699 EJECTION FRACTION DECREASED 94 0.0060
700 PLATELET COUNT DECREASED 644 0.0060
701 URINARY INCONTINENCE 179 0.0060
702 DRUG INTERACTION 958 0.0060
703 DECREASED ACTIVITY 65 0.0060
704 RASH ERYTHEMATOUS 287 0.0060
705 GASTROINTESTINAL PAIN 66 0.0060
706 HEAD INJURY 188 0.0059
707 HYPERTHYROIDISM 86 0.0059
708 HEPATOMEGALY 58 0.0059
709 CHOKING 115 0.0059
710 SKIN INFECTION 66 0.0059
711 CANDIDA INFECTION 99 0.0059
712 INFLUENZA LIKE ILLNESS 482 0.0059
713 UNRESPONSIVE TO STIMULI 151 0.0058
714 DYSURIA 215 0.0058
715 CARDIO-RESPIRATORY ARREST 244 0.0058
716 IMPAIRED WORK ABILITY 124 0.0058
717 PROTEINURIA 110 0.0058
718 MYOCLONUS 69 0.0058
719 INTESTINAL OBSTRUCTION 218 0.0058
720 TRANSIENT ISCHAEMIC ATTACK 195 0.0058
721 DIVERTICULITIS 160 0.0058
722 BLOOD PRESSURE ABNORMAL 114 0.0057
723 DEMENTIA 160 0.0057
724 TOOTH EXTRACTION 71 0.0057
725 DERMATITIS CONTACT 65 0.0057
726 GASTROINTESTINAL HAEMORRHAGE 475 0.0057
727 HYPERGLYCAEMIA 207 0.0057
728 CHILLS 664 0.0057
729 EAR DISCOMFORT 58 0.0056
730 HAEMATEMESIS 143 0.0056
731 VENTRICULAR TACHYCARDIA 93 0.0056
732 FEEDING DISORDER 114 0.0056
733 PERIPHERAL COLDNESS 77 0.0056
734 OSTEONECROSIS 184 0.0056
735 HYPERBILIRUBINAEMIA 58 0.0056
736 PROSTATIC SPECIFIC ANTIGEN INCREASED 77 0.0056
737 EPISTAXIS 418 0.0056
738 VENTRICULAR EXTRASYSTOLES 58 0.0056
739 METASTASES TO LIVER 98 0.0056
740 SKIN EXFOLIATION 469 0.0056
741 BRAIN FOG 87 0.0055
742 RHABDOMYOLYSIS 231 0.0055
743 THROAT IRRITATION 246 0.0055
744 RENAL PAIN 58 0.0055
745 IMMUNE SYSTEM DISORDER 72 0.0055
746 COAGULOPATHY 91 0.0055
747 SOMNOLENCE 1097 0.0054
748 MYALGIA 921 0.0054
749 OROPHARYNGEAL PAIN 501 0.0054
750 SWOLLEN TONGUE 169 0.0054
751 LIMB DISCOMFORT 167 0.0054
752 ABSCESS 86 0.0054
753 BONE LOSS 81 0.0054
754 MASS 75 0.0054
755 FAECES DISCOLOURED 116 0.0053
756 BLOOD PRESSURE DECREASED 355 0.0053
757 POOR QUALITY SLEEP 115 0.0053
758 BREAST CANCER METASTATIC 57 0.0053
759 RASH MACULO-PAPULAR 118 0.0053
760 TINNITUS 242 0.0053
761 LETHARGY 302 0.0052
762 ALANINE AMINOTRANSFERASE INCREASED 322 0.0052
763 CYST 65 0.0052
764 DYSGEUSIA 389 0.0052
765 GAMMA-GLUTAMYLTRANSFERASE INCREASED 116 0.0052
766 ANHEDONIA 137 0.0052
767 PREMATURE DELIVERY 83 0.0052
768 PHOTOPHOBIA 98 0.0052
769 PHOTOSENSITIVITY REACTION 86 0.0052
770 CEREBROVASCULAR ACCIDENT 882 0.0052
771 DRUG LEVEL INCREASED 86 0.0052
772 THYROID DISORDER 80 0.0052
773 HERNIA 100 0.0052
774 HEART RATE INCREASED 509 0.0051
775 RASH PAPULAR 115 0.0051
776 FRACTURE 97 0.0051
777 SPLENOMEGALY 60 0.0051
778 CYTOMEGALOVIRUS INFECTION 85 0.0051
779 CARDIAC DISORDER 478 0.0051
780 MOVEMENT DISORDER 164 0.0051
781 NEUTROPHIL COUNT DECREASED 208 0.0051
782 SCAB 58 0.0051
783 ECZEMA 266 0.0051
784 URINARY RETENTION 169 0.0051
785 CARDIAC ARREST 418 0.0051
786 ACTIVITIES OF DAILY LIVING IMPAIRED 100 0.0050
787 SPINAL PAIN 59 0.0050
788 FEELING COLD 139 0.0050
789 MIDDLE INSOMNIA 93 0.0050
790 HYPOAESTHESIA ORAL 75 0.0050
791 VERTIGO 303 0.0050
792 CARDIOVASCULAR DISORDER 126 0.0050
793 HYPOKINESIA 72 0.0050
794 HYPOGLYCAEMIA 240 0.0049
795 SYNCOPE 493 0.0049
796 LIVER FUNCTION TEST ABNORMAL 143 0.0049
797 NEUROTOXICITY 86 0.0049
798 PRODUCT QUALITY ISSUE 660 0.0049
799 TACHYPNOEA 66 0.0048
800 HYPERSOMNIA 139 0.0048
801 DEPRESSED MOOD 256 0.0048
802 FEELING JITTERY 92 0.0048
803 THIRST 86 0.0048
804 BRADYCARDIA 254 0.0048
805 ELECTROCARDIOGRAM QT PROLONGED 172 0.0048
806 TENDONITIS 74 0.0048
807 DISORIENTATION 189 0.0048
808 PRODUCT USE COMPLAINT 75 0.0048
809 NEUTROPENIA 643 0.0047
810 LYMPHADENOPATHY 167 0.0047
811 TREMOR 779 0.0047
812 SENSORY DISTURBANCE 75 0.0047
813 CONVULSION 267 0.0047
814 PANCREATITIS ACUTE 104 0.0046
815 INTENTIONAL DOSE OMISSION 131 0.0046
816 FUNGAL INFECTION 153 0.0046
817 LOSS OF CONSCIOUSNESS 587 0.0046
818 LIP SWELLING 151 0.0045
819 CHROMATURIA 102 0.0045
820 MUCOSAL INFLAMMATION 118 0.0045
821 ABASIA 111 0.0045
822 THINKING ABNORMAL 83 0.0044
823 SKIN DISCOLOURATION 204 0.0044
824 HERPES ZOSTER 255 0.0044
825 POST PROCEDURAL COMPLICATION 85 0.0044
826 INTERSTITIAL LUNG DISEASE 214 0.0044
827 INCREASED APPETITE 84 0.0044
828 PREMATURE BABY 132 0.0044
829 ACCIDENTAL OVERDOSE 160 0.0044
830 ERYTHEMA 894 0.0043
831 COVID-19 762 0.0043
832 SCAR 74 0.0043
833 HALLUCINATION, VISUAL 91 0.0043
834 AGEUSIA 107 0.0043
835 LACRIMATION INCREASED 129 0.0043
836 HOSPITALISATION 655 0.0043
837 DISSEMINATED INTRAVASCULAR COAGULATION 60 0.0043
838 CARDIAC FAILURE 341 0.0042
839 DERMATITIS 89 0.0042
840 APHONIA 59 0.0042
841 RASH MACULAR 147 0.0042
842 CEREBRAL HAEMORRHAGE 150 0.0042
843 ORAL DISCOMFORT 58 0.0042
844 MENTAL IMPAIRMENT 101 0.0042
845 CORONARY ARTERY OCCLUSION 57 0.0042
846 NERVOUSNESS 216 0.0041
847 CYANOSIS 65 0.0041
848 FEELING ABNORMAL 983 0.0041
849 SKIN CANCER 88 0.0041
850 PALLOR 111 0.0041
851 SWELLING FACE 265 0.0041
852 LUNG NEOPLASM MALIGNANT 167 0.0041
853 EYE PAIN 229 0.0041
854 NEOPLASM PROGRESSION 141 0.0041
855 ORAL HERPES 79 0.0040
856 HYPERHIDROSIS 520 0.0040
857 HALLUCINATION 304 0.0040
858 FEAR 108 0.0040
859 HEAD DISCOMFORT 71 0.0040
860 CONJUNCTIVITIS 74 0.0040
861 HYPOACUSIS 171 0.0040
862 INTENTIONAL DRUG MISUSE 83 0.0040
863 ABDOMINAL PAIN LOWER 100 0.0040
864 BLOOD CREATINE PHOSPHOKINASE INCREASED 113 0.0039
865 ISCHAEMIC STROKE 70 0.0039
866 DRUG INEFFECTIVE 5149 0.0039
867 LYMPHOMA 60 0.0039
868 SPEECH DISORDER 202 0.0039
869 DRY EYE 192 0.0038
870 HAEMORRHAGE INTRACRANIAL 57 0.0038
871 GENERALISED TONIC-CLONIC SEIZURE 63 0.0038
872 FLUSHING 385 0.0038
873 LOCAL SWELLING 66 0.0038
874 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 679 0.0038
875 DISEASE PROGRESSION 445 0.0038
876 HAEMORRHAGE 393 0.0038
877 INTENTIONAL PRODUCT MISUSE 328 0.0037
878 MENTAL DISORDER 163 0.0037
879 FOETAL EXPOSURE DURING PREGNANCY 300 0.0037
880 HEPATIC FAILURE 111 0.0037
881 MUSCULOSKELETAL DISORDER 70 0.0037
882 THERAPEUTIC RESPONSE UNEXPECTED 165 0.0037
883 PRODUCT DOSE OMISSION IN ERROR 104 0.0037
884 DIPLOPIA 95 0.0037
885 MALIGNANT NEOPLASM PROGRESSION 372 0.0036
886 TOOTH LOSS 75 0.0036
887 DRUG ERUPTION 64 0.0036
888 ARRHYTHMIA 171 0.0036
889 BURNING SENSATION 253 0.0036
890 JAUNDICE 97 0.0036
891 EYE SWELLING 134 0.0036
892 ILLNESS 371 0.0036
893 UNEVALUABLE EVENT 270 0.0036
894 BLOOD TRIGLYCERIDES INCREASED 63 0.0036
895 EYE DISORDER 117 0.0036
896 DEAFNESS 93 0.0036
897 INCORRECT PRODUCT ADMINISTRATION DURATION 77 0.0036
898 CRYING 128 0.0035
899 DRUG ADMINISTRATION ERROR 108 0.0035
900 NIGHTMARE 120 0.0035
901 PANIC ATTACK 126 0.0035
902 COLD SWEAT 59 0.0033
903 PRURITUS GENERALISED 72 0.0033
904 RESTLESSNESS 121 0.0033
905 SEIZURE 381 0.0033
906 AGITATION 242 0.0033
907 THROAT TIGHTNESS 89 0.0033
908 SEROTONIN SYNDROME 63 0.0033
909 OCULAR HYPERAEMIA 155 0.0033
910 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 76 0.0033
911 SHOCK 74 0.0032
912 CEREBRAL INFARCTION 77 0.0031
913 BONE MARROW FAILURE 64 0.0031
914 VISION BLURRED 429 0.0031
915 DISEASE RECURRENCE 148 0.0031
916 ABNORMAL BEHAVIOUR 123 0.0031
917 DYSKINESIA 126 0.0031
918 MYOCARDIAL INFARCTION 538 0.0031
919 EMOTIONAL DISORDER 94 0.0030
920 RASH GENERALISED 76 0.0029
921 DRUG DOSE OMISSION 485 0.0029
922 ALTERED STATE OF CONSCIOUSNESS 63 0.0029
923 LACTIC ACIDOSIS 93 0.0029
924 SURGERY 168 0.0029
925 NEOPLASM MALIGNANT 190 0.0028
926 RESPIRATORY ARREST 77 0.0028
927 ANGER 94 0.0028
928 ANAPHYLACTIC REACTION 153 0.0028
929 DRY SKIN 366 0.0027
930 OVERDOSE 591 0.0027
931 EYE PRURITUS 92 0.0027
932 PRODUCT DOSE OMISSION ISSUE 804 0.0027
933 THERAPY INTERRUPTED 194 0.0027
934 EMOTIONAL DISTRESS 327 0.0027
935 DEATH 2312 0.0027
936 DISTURBANCE IN ATTENTION 144 0.0027
937 GASTRIC CANCER 66 0.0026
938 PRODUCT AVAILABILITY ISSUE 59 0.0026
939 BLOOD GLUCOSE DECREASED 124 0.0026
940 EYE IRRITATION 148 0.0026
941 GLYCOSYLATED HAEMOGLOBIN INCREASED 64 0.0025
942 ANAPHYLACTIC SHOCK 65 0.0025
943 NERVOUS SYSTEM DISORDER 78 0.0025
944 DIABETIC KETOACIDOSIS 60 0.0025
945 THERAPEUTIC RESPONSE SHORTENED 79 0.0024
946 PRODUCT DOSE OMISSION 154 0.0024
947 HEPATIC FUNCTION ABNORMAL 88 0.0024
948 INCORRECT DRUG ADMINISTRATION DURATION 66 0.0023
949 WRONG TECHNIQUE IN DRUG USAGE PROCESS 85 0.0023
950 MULTIPLE SCLEROSIS 110 0.0023
951 THERAPY CESSATION 118 0.0023
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 126 0.0023
953 MOOD SWINGS 73 0.0023
954 BLOOD GLUCOSE INCREASED 431 0.0023
955 TOXICITY TO VARIOUS AGENTS 384 0.0023
956 TARDIVE DYSKINESIA 64 0.0023
957 IRRITABILITY 136 0.0023
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 155 0.0022
959 VISUAL ACUITY REDUCED 72 0.0022
960 MULTIPLE SCLEROSIS RELAPSE 143 0.0021
961 BLINDNESS 85 0.0021
962 SUICIDAL IDEATION 187 0.0020
963 INCORRECT DOSE ADMINISTERED 454 0.0020
964 ACNE 148 0.0020
965 ANGIOEDEMA 86 0.0019
966 DRUG EXPOSURE DURING PREGNANCY 63 0.0019
967 DRUG DEPENDENCE 294 0.0018
968 INJECTION SITE MASS 64 0.0017
969 INJECTION SITE ERYTHEMA 214 0.0017
970 VAGINAL HAEMORRHAGE 72 0.0017
971 BREAST CANCER 153 0.0016
972 AGGRESSION 81 0.0016
973 INJECTION SITE HAEMORRHAGE 129 0.0016
974 INJECTION SITE BRUISING 128 0.0016
975 INJECTION SITE PRURITUS 107 0.0016
976 ABORTION SPONTANEOUS 64 0.0016
977 NO ADVERSE EVENT 279 0.0015
978 PROSTATE CANCER 123 0.0015
979 PRODUCT SUBSTITUTION ISSUE 88 0.0015
980 SKIN IRRITATION 68 0.0015
981 INJECTION SITE PAIN 434 0.0014
982 SUICIDE ATTEMPT 83 0.0014
983 SKIN BURNING SENSATION 95 0.0013
984 DRUG EFFECT DECREASED 71 0.0013
985 INJECTION SITE SWELLING 99 0.0013
986 DRUG ABUSE 107 0.0013
987 DEVICE ISSUE 115 0.0013
988 DEPENDENCE 67 0.0012
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 230 0.0011
990 DEVICE MALFUNCTION 79 0.0011
991 INTENTIONAL OVERDOSE 58 0.0009
992 DRUG WITHDRAWAL SYNDROME 70 0.0008